Brief: Glenmark Pharma Sees Europe, Emerging Markets Region Delivering Double-Digit Growth From Q2
14/08/2025 13:37
Aug 14 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: EXPECT EUROPE, EMERGING MARKETS REGION TO DELIVER DOUBLE-DIGIT GROWTH FROM Q2 Source text: ID:nnAZN4DC26R Further company coverage: GLEN.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter